Company intelligence / Profile preview

Chr. Olesen Synthesis

Gentofte / Hvidovre, Hovedstaden, Denmarkcosynthesis.dk ↗

Ownership: Private
Development stage: Commercial

Overview

Chr. Olesen Synthesis operates a modern production facility in Denmark focused on the manufacture of active pharmaceutical ingredients (APIs) and advanced intermediates, with expertise in synthetic chemistry for both food supplement bioenhancers and pharmaceutical industry needs. The company has collaborated with partners such as aXichem to scale up production of specialty compounds like phenylcapsaicin. No clinical trial results are reported as the company is not a drug developer.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Drug pipeline

6 assets

hydromorphone

Commercial

5 more assets in the full pipeline.

Request access →

Partnerships

aXichem AB (collaboration for phenylcapsaicin production)

Beyond the preview

Go deeper on Chr. Olesen Synthesis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chr. Olesen Synthesis.

Explore the full profile